SperiTX Holdings LLC – Trademark Portfolio
Entity Type: 16
SperiTX Holdings LLC holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SPERITEK and SPERITEK CONVENIENCE · COST · CARE. The owner is based in Houston, TX.
952 Echo Lane #322
Houston, TX 77024
Showing of trademarks Trademarks
Trademark Classifications
SperiTX Holdings LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does SperiTX Holdings LLC have?
SperiTX Holdings LLC has 16 U.S. trademarks filed with the USPTO. Of these, 3 registered, 13 abandoned.
What trademark classes does SperiTX Holdings LLC file in?
SperiTX Holdings LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are SperiTX Holdings LLC's most well-known trademarks?
SperiTX Holdings LLC's registered trademark portfolio includes well-known marks such as SPERITEK and SPERITEK CONVENIENCE · COST · CARE. These are among 3 currently registered trademarks in the portfolio.
What is SperiTX Holdings LLC's trademark registration success rate?
SperiTX Holdings LLC has a 19% trademark registration rate, with 3 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.